Related references
Note: Only part of the references are listed.Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial
Pierre Loap et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR
Conrad Chan et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu
Sadaf Aghevlian et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2020)
Residual cancer burden in patients with early stage triple negative breast cancer who progress on anthracycline-based neoadjuvant chemotherapy in an ongoing clinical trial (ARTEMIS)
Haven Garber et al.
CANCER RESEARCH (2020)
Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
Stephen L. Luen et al.
Oncotarget (2019)
Radiation induces apoptosis primarily through the intrinsic pathway in mammalian cells
Xianbin Cao et al.
CELLULAR SIGNALLING (2019)
Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database
Ki-Tae Hwang et al.
CLINICAL CANCER RESEARCH (2019)
Auger electrons for cancer therapy - a review
Anthony Ku et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer
Sadaf Aghevlian et al.
MOLECULAR PHARMACEUTICS (2018)
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
Elli Narvi et al.
SCIENTIFIC REPORTS (2018)
Monte Carlo N-Particle (MCNP) Modeling of the Cellular Dosimetry of 64Cu: Comparison with MIRDcell S Values and Implications for Studies of Its Cytotoxic Effects
Zhongli Cai et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
A less invasive method for orthotopic injection of breast cancer cells into the mouse mammary gland
Luz E. Tavera-Mendoza et al.
LABORATORY ANIMALS (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
Sofia Levva et al.
CANCER GENOMICS & PROTEOMICS (2017)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Paradoxical effects of Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45+ cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice
Dane Bergstrom et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
Abderrahim El Guerrab et al.
ONCOTARGET (2016)
MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using 64Cu-NOTA-panitumumab F(ab')2 fragments
Amanda J. Boyle et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
Heae Surng Park et al.
MODERN PATHOLOGY (2014)
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy
Berengere Piron et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
Minghui Zhang et al.
TARGETED ONCOLOGY (2014)
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
L. Malorni et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer
Aisha Fasih et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
Eun Yoon Cho et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cellular Dosimetry of 111In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity
Zhongli Cai et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer
Dongwei Zhang et al.
CLINICAL CANCER RESEARCH (2009)
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing
Claudia E. Ruebe et al.
CLINICAL CANCER RESEARCH (2008)
Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate
Danny L. Costantini et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons
Jean-Pierre Pouget et al.
RADIATION RESEARCH (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Induction of apoptosis in human tumor cells after exposure to Auger electrons:: comparison with γ-ray exposure
Tetsuro Urashima et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization
HW Lo et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics
A Huether et al.
JOURNAL OF HEPATOLOGY (2005)